Literature DB >> 33208300

Defective immunometabolism pathways in cystic fibrosis macrophages.

Kaitlin Hamilton1, Kathrin Krause1, Asmaa Badr1, Kylene Daily1, Shady Estfanous1, Mostafa Eltobgy1, Arwa Abu Khweek2, Midhun N K Anne1, Cierra Carafice1, Daniel Baetzhold1, Jeffrey R Tonniges3, Xiaoli Zhang4, Mikhail A Gavrilin5, Narasimham L Parinandi5, Amal O Amer6.   

Abstract

BACKGROUND: Mitochondria play a key role in immune defense pathways, particularly for macrophages. We and others have previously demonstrated that cystic fibrosis (CF) macrophages exhibit weak autophagy activity and exacerbated inflammatory responses. Previous studies have revealed that mitochondria are defective in CF epithelial cells, but to date, the connection between defective mitochondrial function and CF macrophage immune dysregulation has not been fully elucidated. Here, we present a characterization of mitochondrial dysfunction in CF macrophages.
METHODS: Mitochondrial function in wild-type (WT) and CF F508del/F508del murine macrophages was measured using the Seahorse Extracellular Flux analyzer. Mitochondrial morphology was investigated using transmission electron and confocal microscopy. Mitochondrial membrane potential (MMP) as well as mitochondrial reactive oxygen species (mROS) were measured using TMRM and MitoSOX Red fluorescent dyes, respectively. All assays were performed at baseline and following infection by Burkholderia cenocepacia, a multi-drug resistant bacterium that causes detrimental infections in CF patients.
RESULTS: We have identified impaired oxygen consumption in CF macrophages without and with B. cenocepacia infection. We also observed increased mitochondrial fragmentation in CF macrophages following infection. Lastly, we observed increased MMP and impaired mROS production in CF macrophages following infection with B. cenocepacia.
CONCLUSIONS: The mitochondrial defects identified are key components of the macrophage response to infection. Their presence suggests that mitochondrial dysfunction contributes to impaired bacterial killing in CF macrophages. Our current study will enhance our understanding of the pathobiology of CF and lead to the identification of novel mitochondrial therapeutic targets for CF.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Bacterial infection; Immunometabolism; Macrophage; Mitochondria; Reactive oxygen species

Mesh:

Year:  2020        PMID: 33208300      PMCID: PMC8121894          DOI: 10.1016/j.jcf.2020.10.006

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  29 in total

1.  GSH monoethyl ester rescues mitochondrial defects in cystic fibrosis models.

Authors:  Mairead Kelly-Aubert; Stéphanie Trudel; Janine Fritsch; Thao Nguyen-Khoa; Maryvonne Baudouin-Legros; Sandra Moriceau; Ludovic Jeanson; Fatima Djouadi; Corine Matar; Marc Conti; Mario Ollero; Franck Brouillard; Aleksander Edelman
Journal:  Hum Mol Genet       Date:  2011-04-25       Impact factor: 6.150

2.  Construction of aminoglycoside-sensitive Burkholderia cenocepacia strains for use in studies of intracellular bacteria with the gentamicin protection assay.

Authors:  Mohamad A Hamad; Alexander M Skeldon; Miguel A Valvano
Journal:  Appl Environ Microbiol       Date:  2010-03-26       Impact factor: 4.792

3.  Depletion of the ubiquitin-binding adaptor molecule SQSTM1/p62 from macrophages harboring cftr ΔF508 mutation improves the delivery of Burkholderia cenocepacia to the autophagic machinery.

Authors:  Basant A Abdulrahman; Arwa Abu Khweek; Anwari Akhter; Kyle Caution; Mia Tazi; Hoda Hassan; Yucheng Zhang; Patrick D Rowland; Sankalp Malhotra; Famke Aeffner; Ian C Davis; Miguel A Valvano; Amal O Amer
Journal:  J Biol Chem       Date:  2012-11-12       Impact factor: 5.157

4.  Autophagy stimulation by rapamycin suppresses lung inflammation and infection by Burkholderia cenocepacia in a model of cystic fibrosis.

Authors:  Basant A Abdulrahman; Arwa Abu Khweek; Anwari Akhter; Kyle Caution; Sheetal Kotrange; Dalia H A Abdelaziz; Christie Newland; Roberto Rosales-Reyes; Benjamin Kopp; Karen McCoy; Richard Montione; Larry S Schlesinger; Mikhail A Gavrilin; Mark D Wewers; Miguel A Valvano; Amal O Amer
Journal:  Autophagy       Date:  2011-11-01       Impact factor: 16.016

5.  Mitochondria-Derived Vesicles Deliver Antimicrobial Reactive Oxygen Species to Control Phagosome-Localized Staphylococcus aureus.

Authors:  Basel H Abuaita; Tracey L Schultz; Mary X O'Riordan
Journal:  Cell Host Microbe       Date:  2018-10-25       Impact factor: 21.023

Review 6.  Contribution of metabolic reprogramming to macrophage plasticity and function.

Authors:  Karim C El Kasmi; Kurt R Stenmark
Journal:  Semin Immunol       Date:  2015-10-09       Impact factor: 11.130

7.  TLR signalling augments macrophage bactericidal activity through mitochondrial ROS.

Authors:  A Phillip West; Igor E Brodsky; Christoph Rahner; Dong Kyun Woo; Hediye Erdjument-Bromage; Paul Tempst; Matthew C Walsh; Yongwon Choi; Gerald S Shadel; Sankar Ghosh
Journal:  Nature       Date:  2011-04-28       Impact factor: 49.962

8.  Disruption of interleukin-1β autocrine signaling rescues complex I activity and improves ROS levels in immortalized epithelial cells with impaired cystic fibrosis transmembrane conductance regulator (CFTR) function.

Authors:  Mariángeles Clauzure; Angel G Valdivieso; María M Massip Copiz; Gustavo Schulman; María Luz Teiber; Tomás A Santa-Coloma
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

9.  Inhibition of autophagy with bafilomycin and chloroquine decreases mitochondrial quality and bioenergetic function in primary neurons.

Authors:  Matthew Redmann; Gloria A Benavides; Taylor F Berryhill; Willayat Y Wani; Xiaosen Ouyang; Michelle S Johnson; Saranya Ravi; Stephen Barnes; Victor M Darley-Usmar; Jianhua Zhang
Journal:  Redox Biol       Date:  2016-11-18       Impact factor: 11.799

10.  Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function.

Authors:  Shuzhong Zhang; Chandra L Shrestha; Benjamin T Kopp
Journal:  Sci Rep       Date:  2018-11-20       Impact factor: 4.379

View more
  2 in total

1.  CFTR-mediated monocyte/macrophage dysfunction revealed by cystic fibrosis proband-parent comparisons.

Authors:  Xi Zhang; Camille M Moore; Laura D Harmacek; Joanne Domenico; Vittobai Rashika Rangaraj; Justin E Ideozu; Jennifer R Knapp; Katherine J Woods; Stephanie Jump; Shuang Jia; Jeremy W Prokop; Russell Bowler; Martin J Hessner; Erwin W Gelfand; Hara Levy
Journal:  JCI Insight       Date:  2022-03-22

2.  Common methods in mitochondrial research (Review).

Authors:  Yiyuan Yin; Haitao Shen
Journal:  Int J Mol Med       Date:  2022-08-25       Impact factor: 5.314

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.